Tuesday 11 December 2018
Home      All news      Contact us      English
reuters - 22 days ago

Trial spotlights U.S. drug safety concerns at compounding pharmacies

A top U.S. Food and Drug Administration official testified on Monday that the agency has concerns about drugs made by compounding pharmacies and still sees problems with them six years after a fungal meningitis outbreak tied to a Massachusetts pharmacy killed 76 people.

Related news

Latest News
Hashtags:   

Trial

 | 

spotlights

 | 

safety

 | 

concerns

 | 

compounding

 | 

pharmacies

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources